Synopsis:
Bharat Rasayan is in focus after fixing December 12 as the record date for its 1:2 stock split and 1:1 bonus issue. The move aims to enhance liquidity as the stock shows mixed long-term and near-term performance.
This company is engaged in manufacturing Technical Grade Pesticides and Intermediates used in the agro-chemical industry is now in the focus after its board set a record date for bonus issue and stock split.
A record date is the cutoff date set by a company to determine which shareholders are eligible to receive benefits such as stock splits or bonus shares. Anyone who owns the stock on or before this date will receive the additional shares, while investors buying the stock after the record date will not be entitled to these corporate benefits.
With market capitalization of Rs. 4,257 cr, the shares of Bharat Rasayan Ltd are currently trading at Rs. 10,245 per share, from its previous close of Rs. 10,319.10 per share. The stock has returned 18% over the past five years, while it posted an 8% decline over the last year, and is down 4% in the past month.
About the update
Bharat Rasayan Ltd announced December 12 as the record date for both its 1:2 stock split and 1:1 bonus issue. Under the split, each existing share of face value Rs 10 will be divided into two shares of Rs 5 each. Alongside this, the company will issue up to 83,10,536 bonus shares of face value Rs 5 for every fully paid-up share held. The allotment of bonus shares is scheduled for December 15, 2025, and trading in these shares is expected to begin from December 16, 2025.
About the company
Bharat Rasayan Ltd is a leading Indian agrochemical manufacturer specializing in technical-grade pesticides, intermediates, and formulations. Known for its strong R&D capabilities and export presence, the company supplies high-quality crop protection products to domestic and global markets. It operates as part of the Bharat Group and is recognized for consistent capacity expansion, backward integration, and long-term partnerships with major multinational agrochemical companies.
The company in Q2FY26 results showed a decline across key financial metrics. Sales fell 13% YoY to Rs. 286 crore from Rs. 328 crore in Q2FY25, while EBITDA dropped 40% YoY to Rs. 33.1 crore. Net profit declined 35% YoY to Rs. 26.2 crore, and EPS also fell 35% YoY to Rs. 62.96 compared to Rs. 96.62 last year.
The company reports a ROCE of 14.3% and a ROE of 11.1%, supported by a low debt-to-equity ratio of 0.08, indicating a strong and conservatively leveraged balance sheet.
Written by Manideep Apppana
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
